HAWK Biosystems — Seed · €760K

HAWK Biosystems, the company renamed from Fastbase Solutions in September 2022, closed its equity crowdfunding round on Capital Cell on 31 March 2023. It raised more than 95% of its €800K target, so the €760K figure is an estimate. The money pays for putting its QF-Pro assay into clinical use and for launching the Violet 3.0 platform. In 2024 the company was also selected for the EIC Accelerator, with €2.5M in grants and up to €4.5M in EIC Fund equity; no closed equity round from that award has been reported, and Innvierte and Hasten Ventures appear only in databases.